Zhejiang Xianju Pharmaceutical Co Ltd (002332) — Financial Flexibility Index
Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Financial Flexibility Index of 0.13x as of September 2025. Free cash flow of CN¥160.05 Million (operating CF CN¥130.05 Million minus capex CN¥30.01 Million) represents 0% of total liabilities (CN¥1.24 Billion). Check Zhejiang Xianju Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Xianju Pharmaceutical Co Ltd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Zhejiang Xianju Pharmaceutical Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see 002332 cash flow conversion.
Annual Financial Flexibility Index for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Xianju Pharmaceutical Co Ltd. Explore 002332 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥456.55 Million | CN¥247.48 Million | CN¥1.18 Billion | ▼ -28.9% |
| 2024 | 0.55x | CN¥606.24 Million | CN¥398.66 Million | CN¥1.11 Billion | ▼ -23.6% |
| 2023 | 0.71x | CN¥830.11 Million | CN¥595.48 Million | CN¥1.16 Billion | ▼ -1.5% |
| 2022 | 0.72x | CN¥891.83 Million | CN¥609.28 Million | CN¥1.23 Billion | ▲ +36.7% |
| 2021 | 0.53x | CN¥942.99 Million | CN¥676.15 Million | CN¥1.78 Billion | ▲ +31.8% |
| 2020 | 0.40x | CN¥907.41 Million | CN¥789.23 Million | CN¥2.26 Billion | ▲ +42.2% |
| 2019 | 0.28x | CN¥782.15 Million | CN¥519.81 Million | CN¥2.77 Billion | ▲ +113.2% |
| 2018 | 0.13x | CN¥362.52 Million | CN¥193.27 Million | CN¥2.73 Billion | ▲ +25.4% |
| 2017 | 0.11x | CN¥290.75 Million | CN¥167.47 Million | CN¥2.75 Billion | ▼ -42.1% |
| 2016 | 0.18x | CN¥253.01 Million | CN¥155.91 Million | CN¥1.38 Billion | ▼ -25.2% |
| 2015 | 0.24x | CN¥314.65 Million | CN¥199.61 Million | CN¥1.29 Billion | ▲ +54.1% |
| 2014 | 0.16x | CN¥249.89 Million | CN¥141.64 Million | CN¥1.57 Billion | ▼ -1.3% |
| 2013 | 0.16x | CN¥252.72 Million | CN¥63.46 Million | CN¥1.57 Billion | ▼ -39.8% |
| 2012 | 0.27x | CN¥331.44 Million | CN¥33.43 Million | CN¥1.24 Billion | ▼ -45.5% |
| 2011 | 0.49x | CN¥421.77 Million | CN¥147.63 Million | CN¥860.02 Million | ▲ +57.9% |
| 2010 | 0.31x | CN¥217.87 Million | CN¥155.29 Million | CN¥701.29 Million | ▲ +63.8% |
| 2009 | 0.19x | CN¥147.62 Million | CN¥104.68 Million | CN¥778.28 Million | ▲ +48.8% |
| 2008 | 0.13x | CN¥95.28 Million | CN¥36.03 Million | CN¥747.44 Million | ▼ -49.9% |
| 2007 | 0.25x | CN¥164.08 Million | CN¥96.53 Million | CN¥644.44 Million | ▲ +68.7% |
| 2006 | 0.15x | CN¥89.56 Million | CN¥53.05 Million | CN¥593.35 Million | — |